Related Subjects:
| Oncological Emergencies
| Acute Myeloid Leukaemia (AML)
| Acute Lymphoblastic Leukaemia (ALL)
| Chronic Lymphocytic Leukaemia (CLL)
| Chronic Myeloid Leukaemia (CML)
| Immune Thrombocytopenic Purpura (ITP)
| Multiple Myeloma
| Graft-versus-Host Disease (GVHD)
| Cytomegalovirus (CMV) Infections
|Flow Cytometry
|Haematology Laboratory Values
|Indications for Irradiated Blood Products
๐ฉธ Irradiated blood products are used to prevent transfusion-associated graft-versus-host disease (TA-GVHD) โ a rare but usually fatal complication in which viable donor T-lymphocytes engraft and attack the recipientโs tissues.
โข๏ธ Irradiation inactivates donor lymphocytes while preserving red cell function, making transfusion safer in high-risk patients.
๐งฌ What is TA-GVHD? (Why irradiation matters)
- ๐ฅ Donor T-cells survive in the transfused blood.
- โ๏ธ They recognise the recipient as โforeignโ.
- ๐ฅ They attack skin, liver, gut, and bone marrow.
- ๐ This leads to pancytopenia, sepsis, and multiorgan failure.
- โ ๏ธ Mortality >90% โ prevention is essential.
๐ Indications for Irradiated Blood Products
- ๐๏ธ Hodgkinโs Lymphoma (Lifelong indication)
- Causes long-lasting T-cell dysfunction.
- Risk persists even after remission.
- โก๏ธ All blood must be irradiated for life.
- ๐งช Stem Cell / Bone Marrow Transplant Recipients
- Includes autologous and allogeneic transplants.
- Conditioning destroys immune surveillance.
- Donor lymphocytes can engraft easily.
- โก๏ธ Irradiated blood needed until immune recovery.
- ๐งฌ Donor Lymphocyte Infusions (DLI)
- Highly immunogenic donor T-cells.
- Extreme GVHD risk.
- ๐ฆ Granulocyte Transfusions
- Contain large numbers of active lymphocytes.
- High TA-GVHD risk.
- โก๏ธ Must always be irradiated.
- ๐ง Congenital Immunodeficiency Disorders
- Examples: SCID, DiGeorge syndrome.
- Impaired T-cell function โ cannot reject donor cells.
- โก๏ธ Absolute indication.
- ๐คฐ Intrauterine Transfusions (IUT)
- Fetal immune system is immature.
- Cannot mount rejection response.
- โก๏ธ Blood must be irradiated.
- ๐ถ Neonatal Exchange Transfusions
- Large donor lymphocyte exposure.
- High vulnerability.
- โก๏ธ Irradiation mandatory.
- ๐ Purine Analogue Therapy
- Examples: fludarabine, cladribine, pentostatin.
- Profound, prolonged T-cell depletion.
- Risk may persist for years.
- ๐จโ๐ฉโ๐งโ๐ฆ First-Degree Relative Donations
- Partial HLA matching.
- Donor cells evade immune detection.
- โก๏ธ High TA-GVHD risk.
- ๐ฉบ Post-Splenectomy (Selected Patients)
- Mainly if underlying haematological disease.
- Reduced immune clearance.
โณ Duration of Irradiation Requirement
- ๐งฌ Allogeneic HSCT
- From start of conditioning.
- Continue โฅ 6โ12 months.
- Longer if GVHD/immunosuppression persists.
- ๐ Autologous HSCT
- During conditioning.
- Continue โฅ 3 months post-transplant.
- ๐ Purine Analogue Therapy
- Minimum 6 months.
- Often lifelong (local policy dependent).
- ๐ถ Neonates after IUT
- Continue until 6 months of age.
- ๐๏ธ Hodgkinโs Lymphoma
- โก๏ธ Lifelong requirement.
โ ๏ธ Important Practical Points
- ๐ Irradiation does NOT prevent CMV transmission.
- ๐ง Does NOT remove potassium (use washed cells if hyperkalaemia risk).
- ๐ Shortens red cell shelf-life (28 days post-irradiation).
- ๐ชช Patients should carry an irradiated blood alert card.
๐ Exam & Clinical Pearls
- โญ Hodgkinโs lymphoma = irradiated blood for life.
- โญ Relatives donating blood = always irradiate.
- โญ Fludarabine = think irradiation.
- โญ TA-GVHD = pancytopenia + rash + diarrhoea + liver failure.
- โญ Prevention is the only effective treatment.
๐ References (UK-Based)